Related Experiment Video
Updated: Mar 15, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Myelodysplastic syndrome without ring sideroblasts and with Janus kinase 2 gene mutation: An unusual case report
Maria Helena Ornellas1, Monique De França Silva2, Cristiana Solza3
1Department of Pathology, Laboratory of Circulating Markers, Faculty of Medical Sciences (FCM), Rio de Janeiro 20550-170, Brazil; Graduation Course in Medical Sciences, Faculty of Medical Sciences (FCM), Rio de Janeiro 20550-170, Brazil.
Abstract:
Myelodysplastic syndrome (MDS) cases comprise a heterogeneous group of hematological disorders that are characterized by impaired hematopoiesis, with cytopenias of different grades and risk of developing acute myeloid leukemia. MDS may rarely be associated with thrombocytosis. In such cases, myelodysplasia and myeloproliferative disorders may overlap, making correct diagnosis difficult. We herein describe a case of MDS with thrombocytosis, Janus kinase 2 gene mutation-positive and Perls' staining-negative, which was initially classified as essential thrombocythemia (ET). This case highlights that MDS may be misdiagnosed as ET and inappropriate treatment may be initiated. Therefore, it is crucial to carefully combine all available data on morphology and immunophenotyping, and to perform the necessary molecular, cytogenetic and molecular cytogenetic analyses, in order to correctly diagnose this disease.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
The JAK-STAT Signaling Pathway
Abnormal Proliferation
Satellite Stem Cells and Muscular Dystrophy
PI3K/mTOR/AKT Signaling Pathway
Mesenchymal Stem Cells

